(1) Each organization or practice that receives a grant through the pilot program shall submit an annual report to the college of nursing by a date set by the college of nursing. At a minimum, the report must include the following information:

(a) The amount of the grant and the date on which the grant was received;

(b) An accounting of how the grant money was spent and whether any grant money was not expended;

(c) The number of nurse practitioners or physician assistants who were trained and who received certification to prescribe buprenorphine and all other medications and therapies approved by the federal food and drug administration to treat opioid use disorder; and

(d) A detailed description of the training received by nurse practitioners or physician assistants; whether the nurse practitioners or physician assistants completed the training and attained status as a qualified nurse practitioner or physician assistant; whether the nurse practitioners or physician assistants that attained qualified nurse practitioner or physician assistant status are currently able to provide and are providing medication-assisted treatment to opioid-dependent patients; the number of individuals with opioid use disorders treated in the previous two years before the pilot program; and the number of opioid-dependent patients treated during the pilot program period by each qualified nurse practitioner or physician assistant.

(2) On or before June 30, 2018, and on or before June 30, 2019, the college of nursing shall submit a summarized report on the pilot program to the health and human services committee of the senate and the health, insurance, and environment and public health care and human services committees of the house of representatives, or any successor committees, and to the governor. At a minimum, the report must include:

(a) A description of the pilot program;

(b) A list identifying the grant recipients, including the amount awarded to each grant recipient and a detailed description of how each grant recipient used the grant award;

(c) The total number of nurse practitioners and physician assistants who completed the required training and became certified to prescribe buprenorphine, listed by county participating in the pilot program;

(d) The total number of patients served during the course of the pilot program, listed by county participating in the pilot program;

(e) A summary of policies and procedures instituted by grant recipients related to the provision of MAT by qualified nurse practitioners and physician assistants;

(f) A summary of evaluation results of the pilot program; and

(g) A summary of lessons learned and recommendations for implementing MAT as provided by nurse practitioners and physician assistants in other communities in the state.